PCR Machines in Wisconsin

Werfen (formerly Immucor, Inc.) is a global leader in specialized diagnostics for transfusion and transplantation medicine. The company manufactures a comprehensive portfolio of serology-based reagents, automated instruments, and molecular diagnostic products serving blood banks, transfusion services, clinical laboratories, reference laboratories, donor centers, and transplant programs worldwide. Core product lines include: (1) Transfusion diagnostics—blood typing, antibody screening and identification, platelet serology, and HLA donor screening assays; (2) Transplant diagnostics—HLA typing kits (including NanoTYPE® HLA-11 Plus), HLA and non-HLA antibody detection products, and post-transplant monitoring assays; and (3) Coagulation diagnostics for heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP) detection. Signature automated platforms include the NEO® and NEO Iris® systems for immunohematology automation, and Echo Lumena® for antibody identification with enhanced imaging. The company acquired Omixon (Hungary) to expand HLA typing capabilities. Werfen operates globally across hospital blood banks, reference laboratories, and transplant centers, leveraging customer-centric support with field representatives who possess transfusion and transplant technical expertise. The company emphasizes regulatory compliance, quality assurance, and comprehensive technical and educational support to streamline laboratory workflows and improve patient outcomes in transfusion and transplant medicine.

Promega Corporation is a global life science reagent and instrument manufacturer specializing in assays, reagents, and detection systems for research, drug discovery, clinical diagnostics, and forensic applications. The company develops bioluminescent reporter systems (NanoLuc® Luciferase, firefly luciferase), qPCR and RT-qPCR master mixes (GoTaq® systems), cell viability and apoptosis assays (CellTiter-Glo®, Caspase-Glo®), kinase selectivity profiling platforms (NanoBRET® systems), and imaging instrumentation (GloMax® Galaxy bioluminescence imager). Primary markets include small-molecule drug discovery, cell and gene therapy development, clinical research and molecular diagnostics, human identification (forensic DNA analysis), and academia. Manufacturing and R&D operations in Madison, Wisconsin are ISO 9001 (Quality Management Systems) and ISO 14001:2015 (Environmental Management Systems) certified. Products are manufactured under stringent quality control standards suitable for regulated clinical and diagnostic applications. Technical support and customer service resources include protocols, certificates of analysis, safety data sheets, and dedicated technical services scientists. The company serves pharmaceutical, biotech, clinical laboratory, forensic, and academic research markets globally.

Genesystem Co., Ltd. is a South Korean biotech engineering company specializing in point-of-care molecular diagnostic solutions. The company develops rapid PCR-based testing platforms utilizing proprietary biochip and ultra-fast PCR technologies for on-site molecular diagnostics. Primary product lines include the UF-series instruments (UF-300, UF-340, UF-100, UF-150) designed for rapid DNA amplification and qPCR applications, complemented by consumables including Rapi:chip cartridges, PCR reagents optimized for ultra-fast performance, and nucleic acid extraction kits. Assay portfolio spans human pathogen detection (SARS-CoV-2, influenza, RSV, tuberculosis, HPV, STIs), veterinary diagnostics (canine and feline disease panels for skin, respiratory, gastrointestinal, and neurological conditions; livestock diagnostics for ASFV, SBV, FMDV), and food safety applications (foodborne pathogen detection, halal assurance, meat authentication). The company emphasizes multiplex capability, rapid sample-to-result turnaround (20-minute DNA amplification), and miniaturized heating module technology. Genesystem exhibits internationally at major diagnostic conferences (MEDICA, AACC, IFCC) and maintains a global network of distributors. Manufacturing and R&D focus on biochip-based multiplex POCT solutions with expansion into biomarker development and diversified multiplex diagnostic applications.